Fatty acids in cystic fibrosis

Area of Science:

• Biochemistry
• Genetics
• Physiology

Background:

• Cystic fibrosis (CF) is associated with essential fatty acid deficiencies.
• Previous research suggested these deficiencies stemmed from malnutrition, but recent studies indicate they are independent of nutritional status.
• Prior studies focused on plasma, not CF-affected tissues.

Purpose of the Study:

• To investigate fatty acid abnormalities in CF-affected tissues.
• To determine the effect of docosahexaenoic acid (DHA) supplementation on these abnormalities and associated inflammation.

Main Methods:

• Analysis of membrane-bound fatty acids in the pancreas, lungs, and ileum of CF knock-out mice.
• Oral administration of DHA to CF knock-out mice.
• Assessment of neutrophil infiltration in the lungs.

Main Results:

• CF knock-out mice exhibited increased arachidonic acid and decreased docosahexaenoic acid (DHA) levels in key tissues.
• Oral DHA administration normalized these lipid levels.
• DHA therapy reduced neutrophil infiltration in the lungs of CF mice.

Conclusions:

• CF gene mutations induce specific lipid abnormalities in affected tissues.
• DHA supplementation can reverse these lipid abnormalities and ameliorate lung inflammation in a CF mouse model.
• Further research is needed to elucidate the precise mechanisms linking CF mutations to lipid dysregulation.